Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Jazz Pharma Plc (JAZZ)

Jazz Pharma Plc (JAZZ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 10,400,536
  • Shares Outstanding, K 60,765
  • Annual Sales, $ 4,069 M
  • Annual Income, $ 560,120 K
  • EBIT $ 150 M
  • EBITDA $ 810 M
  • 60-Month Beta 0.27
  • Price/Sales 2.51
  • Price/Cash Flow 5.63
  • Price/Book 2.62

Options Overview Details

View History
  • Implied Volatility 29.68% (-3.08%)
  • Historical Volatility 32.05%
  • IV Percentile 10%
  • IV Rank 19.91%
  • IV High 69.53% on 08/05/25
  • IV Low 19.77% on 01/21/25
  • Expected Move (DTE 35) 12.07 (7.08%)
  • Put/Call Vol Ratio 0.02
  • Today's Volume 767
  • Volume Avg (30-Day) 757
  • Put/Call OI Ratio 0.36
  • Today's Open Interest 17,143
  • Open Int (30-Day) 15,492
  • Expected Range 158.42 to 182.56

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 16 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate 5.43
  • Number of Estimates 7
  • High Estimate 5.81
  • Low Estimate 5.09
  • Prior Year 5.70
  • Growth Rate Est. (year over year) -4.74%

Price Performance

See More
Period Period Low Period High Performance
1-Month
156.95 +8.98%
on 01/08/26
175.80 -2.71%
on 01/05/26
+1.31 (+0.77%)
since 12/16/25
3-Month
128.80 +32.80%
on 11/07/25
182.99 -6.53%
on 11/18/25
+36.79 (+27.40%)
since 10/16/25
52-Week
95.49 +79.12%
on 04/09/25
182.99 -6.53%
on 11/18/25
+48.42 (+39.49%)
since 01/16/25

Most Recent Stories

More News
3 Small-Cap Stocks That Fall Short

3 Small-Cap Stocks That Fall Short

JAZZ : 169.99 (-0.68%)
MSM : 84.63 (-1.74%)
CHPT : 7.09 (+2.90%)
Jazz Pharmaceuticals Appoints Thomas Riga as Chief Business Officer

Mr. Riga brings over 25 years of commercial and operational experience with proven success leading transformative corporate development strategies and transactions

JAZZ : 169.99 (-0.68%)
Ziihera® (zanidatamab-hrii) Combinations Achieve Unprecedented Results in First-Line HER2+ Locally Advanced or Metastatic GEA Including More Than Two Years Median Overall Survival Benefit

Positive Phase 3 HERIZON-GEA-01 results support Ziihera as the HER2-targeted agent-of-choice in HER2+ first-line metastatic GEA and Ziihera plus chemotherapy to replace trastuzumab as the new...

JAZZ : 169.99 (-0.68%)
Reflecting On Pharmaceuticals Stocks’ Q3 Earnings: Jazz Pharmaceuticals (NASDAQ:JAZZ)

Reflecting On Pharmaceuticals Stocks’ Q3 Earnings: Jazz Pharmaceuticals (NASDAQ:JAZZ)

JAZZ : 169.99 (-0.68%)
3 Mid-Cap Stocks with Warning Signs

3 Mid-Cap Stocks with Warning Signs

GL : 139.17 (-0.46%)
JAZZ : 169.99 (-0.68%)
CNC : 46.29 (-2.07%)
3 Reasons JAZZ is Risky and 1 Stock to Buy Instead

3 Reasons JAZZ is Risky and 1 Stock to Buy Instead

JAZZ : 169.99 (-0.68%)
Jazz Pharmaceuticals to Participate in Upcoming Investor Events

DUBLIN , Dec. 17, 2025 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the Company will participate in the following investor events:

JAZZ : 169.99 (-0.68%)
3 Value Stocks We’re Skeptical Of

3 Value Stocks We’re Skeptical Of

JAZZ : 169.99 (-0.68%)
BAND : 13.51 (-0.15%)
FDX : 309.80 (-1.07%)
Jazz Pharmaceuticals to Present Extensive New Data and Real-World Evidence Highlighting Epidiolex® (cannabidiol) Outcomes in Treatment-Resistant Epilepsies at the American Epilepsy Society 2025 Annual Meeting

New interim results from the EpiCom trial, a prospective evaluation of behavioral outcomes in patients with tuberous sclerosis complex, suggest improvements in non-seizure outcomes

JAZZ : 169.99 (-0.68%)
3 Healthcare Stocks We’re Skeptical Of

3 Healthcare Stocks We’re Skeptical Of

JAZZ : 169.99 (-0.68%)
AZTA : 39.79 (-0.30%)
AMRX : 13.31 (+0.91%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Jazz Pharmaceuticals is a specialty biopharmaceutical company with a focus in the areas of neuroscience & oncology. It derives the majority of its revenues from its sleep disorder drugs' Xywav & Xyrem. Both drugs are approved for treating cataplexy & excessive daytime sleepiness in narcolepsy patients....

See More

Key Turning Points

3rd Resistance Point 178.70
2nd Resistance Point 175.60
1st Resistance Point 173.38
Last Price 169.99
1st Support Level 168.06
2nd Support Level 164.96
3rd Support Level 162.74

See More

52-Week High 182.99
Last Price 169.99
Fibonacci 61.8% 149.57
Fibonacci 50% 139.24
Fibonacci 38.2% 128.91
52-Week Low 95.49

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar